Cleared Special

K120979 - CAREFUSION NICOLET EDX

K120979 is an FDA 510(k) clearance for CAREFUSION NICOLET EDX, manufactured by Carefusion 209, Inc.. The device is a Class 2 Neurology device with product code GWF cleared through the Special 510(k) pathway after a 23-day FDA review.

K120979 · Carefusion 209, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2012
Decision
23d
Days
Class 2
Risk

K120979 is an FDA 510(k) clearance for the CAREFUSION NICOLET EDX. Classified as Stimulator, Electrical, Evoked Response (product code GWF), Class II - Special Controls.

Submitted by Carefusion 209, Inc. (Middleton, US). The FDA issued a Cleared decision on April 25, 2012 after a review of 23 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1870 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Carefusion 209, Inc. devices

FDA 510(k) Submission Details - K120979

510(k) Number K120979 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 02, 2012
Decision Date April 25, 2012
Days to Decision 23 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
125d faster than avg
Panel avg: 148d · This submission: 23d
Pathway characteristics
Modification to existing cleared device.

GWF Device Classification - Class 2, Special Controls

Product Code GWF Stimulator, Electrical, Evoked Response
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1870
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWF Stimulator, Electrical, Evoked Response

All 69
Devices cleared under the same product code (GWF) and FDA review panel - the closest regulatory comparables to K120979.
MEP Monitor
K162873 · Tonica Elektronik A/S · Mar 2017
MagPro R20
K160280 · Tonica Elektronik A/S · May 2016
Neuromaster G1 MEE200
K142624 · Nihon Kohden Corporation · Apr 2015
MODIFCATION TO: NUVASIVE NEUROVISION EMG ENDOTRACHEAL TUBE
K094054 · Nuvasive, Inc. · May 2010
MAGPRO, MODELS R30 WITH MAGOPTION, X100, X100 WITH MAGOPTION
K091940 · Tonica Elektronik A/S · Mar 2010
NUVASIVE NEURO VISION SYSTEM
K090298 · Nuvasive, Inc. · Jun 2009